Curing malaria together

摘要

Fuelled by the rapid spread of resistance to standard antimalarial drugs, deaths from malaria have doubled in many parts of sub-Saharan Africa and forced first-line drug policy changes in much of Asia. In Africa, resistance levels to chloroquine, the cheapest standard drug, are often as high as 80%. More effective drugs are becoming available, but their costs and the investments necessary to scale up production have hampered their widespread use in the poorest disease endemic countries.